Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
46.25
-1.28 (-2.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi-Aventis S.A. ADR
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
28
29
Next >
How Siga Is Turning Its Biowarfare Soldier Onto This Outbreak ... And The Next
August 04, 2022
Siga stock more than tripled, emerging from under the radar to take on the outbreak.
Via
Investor's Business Daily
Regeneron's Prostate Cancer Combo Candidate Shows Encouraging Anti-Tumor Activity
August 03, 2022
Via
Benzinga
A Bearish Sign Appears On Sanofi's Chart
August 03, 2022
If history is any guide, there may be trouble ahead for shares of Sanofi (NASDAQ:SNY). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Via
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Sanofi Ekes Out Narrow Beat As Eczema Giant Scores Massive Gain
July 28, 2022
The company reported more than 40% growth for Dupixent in the second quarter.
Via
Investor's Business Daily
Sanofi Raises Annual Guidance On Upbeat Q2 Performance
July 28, 2022
Via
Benzinga
Daily Stock Analysis: Sanofi S.A.
July 19, 2022
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. It was founded in 1973 and is headquartered in Paris.
Via
Talk Markets
3-D Portfolio: Discounts, Diversification, And Dividends
July 31, 2022
When it comes to high-yield closed-end funds, I’m a big fan of the “three Ds” — discounts, diversification, and dividends. Today, we’ll look at a three-fund, bargain-priced “3-D” CEF portfolio you can...
Via
Talk Markets
Week In Review: China Biopharma Tops $2.8 Billion In Week's Dealmaking
July 30, 2022
CSPC Pharma out-licensed global rights for its antibody drug conjugate targeting Claudin18.2 to Elevation Oncology of New York City. CSPC will receive a $27 million upfront payment and up to $148...
Via
Talk Markets
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
July 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea
July 28, 2022
Pasithea Therapeutics Corp. (NASDAQ: KTTA), a biotech company looking for new treatments for psychiatric and neurological disorders, received an AU$1 million (US$694,000) gran
Via
Benzinga
Sanofi's Fitusiran Prophylaxis Cuts Bleeds By 61% In Hemophilia Patients
July 11, 2022
Via
Benzinga
Earnings Scheduled For July 28, 2022
July 28, 2022
Companies Reporting Before The Bell • ArcelorMittal (NYSE:MT) is estimated to report earnings for its second quarter.
Via
Benzinga
Earnings Outlook For Sanofi
July 27, 2022
Sanofi (NASDAQ:SNY) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that Sanofi will report an...
Via
Benzinga
Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product
July 25, 2022
Via
Benzinga
Amid RNA Setbacks, Start Up Bets On Sanofi's siRNA Platform
July 25, 2022
Via
Benzinga
Apple, Meta, Pfizer Among Key Companies Reporting In The Week Ahead, As Earning Picks Up Pace
July 24, 2022
Big tech earnings will flow in thick and fast in the upcoming week, providing more clarity on how supply chain disruptions and the macroeconomic malaise have impacted these companies.
Via
Benzinga
Pasithea's Latest Drug Candidate Could Bring New Hope To ALS Patients Without Effective Treatment Options
July 20, 2022
Amyotrophic lateral sclerosis (ALS) is a rare but painful and fatal disease that slowly shuts down all voluntary movements in the body, from walking to breathing.
Via
Benzinga
Analyzing Sanofi's Short Interest
July 19, 2022
Sanofi's (NASDAQ:SNY) short percent of float has fallen 14.29% since its last report. The company recently reported that it has 3.00 million shares sold short, which is 0.12% of...
Via
Benzinga
Clovis Oncology (CLVS) Stock Pops 7% on Supply Agreement
July 19, 2022
CLVS stock is rallying 7% after Clovis Oncology made a major deal with NorthStar Medical. Takeover speculation has swirled around Clovis.
Via
InvestorPlace
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine
July 18, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Regeneron-Sanofi's Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years
July 14, 2022
Via
Benzinga
Sanofi Offloads 17 Products To Neuraxpharm
July 13, 2022
Sanofi SA (NASDAQ: SNY) has entered a deal to hand over 17 products to central nervous system (CNS) specialist Neuraxpharm for an undisclosed sum.
Via
Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
July 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
SOBI-Sanofi Partnered Hemophilia Therapy Shows Superior Bleed Protection Than Prior Prophylaxis
July 11, 2022
Via
Benzinga
Biotech Stocks To Watch And Pharma Industry News
July 08, 2022
Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
Via
Investor's Business Daily
This New York-Based Digital Therapeutics Company Looks To Disrupt a $475 Billion Market
July 07, 2022
As the global coronavirus pandemic forced people to keep their distance from one another, there has been an increase in the adoption of digital health solutions among healthcare professionals and...
Via
Benzinga
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Sanofi with Losses of $100,000 to Contact the Firm
July 05, 2022
From
The Schall Law Firm
Via
Business Wire
The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study
July 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.